Synopsis
The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric system by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Transdermal Patch of an Antihypertensive Drug: Transdermal...
Image fournie par le vendeur
Transdermal Patch of an Antihypertensive Drug
Edité par
LAP LAMBERT Academic Publishing Dez 2017, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric system by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio. 108 pp. Englisch. N° de réf. du vendeur 9786202026475
Acheter neuf
EUR 49,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Transdermal Patch of an Antihypertensive Drug
Edité par
LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Couverture souple
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kumar Yadav Pavan1. Pawan kumar yadavDepartment of PharmacyM. J. P. Rohilkhand University, Bareilly (U.P.)2. Miss Preeti PalDepartment of PharmacyM. J. P. Rohilkhand University, Bareilly (U.P.)3. Deepak kumarDepartment of Applied Che. N° de réf. du vendeur 385901921
Acheter neuf
EUR 41,71
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image d'archives
Transdermal Patch of an Antihypertensive Drug: Transdermal Patch
Edité par
LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Paperback
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Paperback. Etat : Brand New. 108 pages. 8.66x5.91x0.25 inches. In Stock. N° de réf. du vendeur zk6202026472
Acheter neuf
EUR 87,81
Expédition à EUR 11,53
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Transdermal Patch of an Antihypertensive Drug
Edité par
LAP LAMBERT Academic Publishing Dez 2017, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric system by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 108 pp. Englisch. N° de réf. du vendeur 9786202026475
Acheter neuf
EUR 49,90
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Transdermal Patch of an Antihypertensive Drug : Transdermal Patch
Edité par
LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric system by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio. N° de réf. du vendeur 9786202026475
Acheter neuf
EUR 50,50
Expédition à EUR 60,90
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Transdermal Patch of an Antihypertensive Drug | Transdermal Patch
Edité par
LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202026472
ISBN 13 : 9786202026475
Neuf
Taschenbuch
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Transdermal Patch of an Antihypertensive Drug | Transdermal Patch | Pavan Kumar Yadav (u. a.) | Taschenbuch | 108 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9786202026475 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 110794344
Acheter neuf
EUR 44
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)